A necrotrophic fungus that affects many plant species. Also known as grey mold or bud rot, exposure can result in “winegrower’s lung” a rare form of hypersensitivity pneumonitis (a respiratory allergic reaction in predisposed individuals).
To address these concerns, producers have resorted to third party Quality Assurance, sending cannabis to labs to be tested for bacteria, fungus, and mold. If a product has been found to have unacceptable levels of fungus or bacteria, producers have used gamma radiation to reduce or eliminate the contamination. The irradiated cannabis is then sent back for retesting. It is important to note that this transfer and travel time removes the cannabis from its controlled and Quality Assurance environment, further increasing risk of contamination. Also, many patients are becoming concerned about the use of radiation to treat products for ingestion, as well as the fact that it is not a risk-free mechanism for eradicating mold and other adulterants. It is also known that radiation can destroy the essential oils, called terpenes, which are naturally produced by the cannabis plant and can play an important synergistic role in therapeutic response.
Microbial contaminants in Medical Marijuana can be harmful to patients, with particular risk for the immunocompromised and critically ill. With the increasing use of edible forms of cannabis, as well as vaporization, it has become essential for the patient to know that their cannabis is free of all contaminants. We at THC Therapeutics have designed the dHydronator with built-in technology to effectively minimize the health risks associated with the ingestion of contaminated cannabis. Additionally, the dHydronator is scientifically proven to maintain the integrity of the organic matter, terpenes, pollen and herbal potency throughout the sanitizing process. It is with these concerns in mind that we continue to develop the technology to provide consistency and safety to medical and recreational cannabis users alike.
THC Therapeutics becomes Millennium Blockchain
Millennium Blockchain is being formed as a holding company investing and developing in decentralized systems and distributed ledger technologies. As part of the transition, the Company is in preliminary discussions for legacy cannabis-related assets to be sold or spun-out.
Additionally, Millennium Blockchain is forming a new board of directors and has elected a new Chairman of the Board of Directors, Enzo Villani, who has acquired a significant stake in Millennium Blockchain to become the second-largest shareholder in the Company. He is currently the Managing Director for the prestigious blockchain advisory and communications company, Transform Group International (www.transformgroup.io). Mr. Villani is the former Managing Director of Nasdaq and was co-founder of Nasdaq Global Corporate Solutions and has completed over $500 million in mergers and acquisitions in the technology and communications sectors. Mr. Villani was also CEO and Board Member of Equities.com